GC
MIRM icon

Guggenheim Capital’s Mirum Pharmaceuticals MIRM Stock Holding History

Guggenheim Capital’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
10,692
-3,796
-26% -$381K 0.01% 927
2026
Q1 		$1.34M Buy
14,488
+4,716
+48% +$444K 0.01% 869
2025
Q4 		$772K Buy
+9,772
New +$701K 0.01% 1070

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Guggenheim Capital's MIRM Position: Q2 2026 in Review

Guggenheim Capital reduced its Mirum Pharmaceuticals (MIRM) stake by 26% in Q2 2026, selling an estimated $381K and leaving 10,692 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #927.

Guggenheim Capital first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.34M in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Guggenheim Capital held 10,692 shares of Mirum Pharmaceuticals worth $1.25M as of Q2 2026.
  • Guggenheim Capital sold 3,796 Mirum Pharmaceuticals shares in Q2 2026, an estimated $381K.
  • Mirum Pharmaceuticals made up 0.01% of Guggenheim Capital's portfolio in Q2 2026, its #927 holding.
  • Guggenheim Capital first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Guggenheim Capital's Mirum Pharmaceuticals position peaked at $1.34M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.